Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2020 / N 3

Качество жизни пациентов с бронхиальной астмой: влияние монтелукаста
А.В. Емельянов, А.С. Белевский

References

1. What quality of life? The WHOQOL Group. World Health Organization Quality of Life Assessment. World Health Forum 1996;17(4):354-6.
2. Quality of life. In: Medical encyclopedia. Chicago: The World Book; 1995: 744.
3. Senkevich NYu, Belevskiy AS. Quality of life – subject of scientific research in pulmonology: based on materials of the International Congress Interastma-98 and the 8th National Congress on Respiratory Diseases. Therapeutic Archive 1999;71(3):36-41 (In Russian).
4. Senkevich NYu. Quality of life in chronic obstructive pulmonary disease. In: Chronic obstructive pulmonary diseases. Chuchalin AG, editor. Moscow: Binom; 1998: 171-91 (In Russian).
5. Yevsina OV. Quality of life in medicine – an important indicator of patient’s health (literature review). Personality in a Changing World: Health, Adaptation, Development 2013;1(1):119-33 (In Russian).
6. Juniper EF, Guyatt GH, Ferrie PJ, Criffith LE. Measurement quality of life in asthma. The American Reviews of Respiratory Disease 1993 Apr;147(4):832-8.
7. Juniper EF. Assessing asthma quality of life: its role in clinical practice. Breath 2005 Mar;1(3):193-204.
8. Yemelyanov AV, Sinitsina TM, Rudinskшy KA, Krasnoshchekova OI, Fedulov AV, Zinakova MK. Quality of life and indicators of external respiratory function in patients with bronchial asthma. Therapeutic Archive 2001;73(12):63-5 (In Russian).
9. Miligkos M, Bannuru RR, Alkofide H, Kher SR, Schmid CH, Balk EM. Leukotriene- receptor antagonists versus placebo in the treatment of asthma in adults and adolescents, a systematic review and meta-analysis. Annals of Internal Medicine 2015 Nov;163(10):756-67.
10. Zhang HP, Jia CE, Lv Y, Gibson PG, Wang G. Montelukast for prevention and treatment of asthma exacerbations in adults: systematic review and meta-analysis. Allergy & Asthma Proceedings 2014 Jul-Aug;35(4):278-87.
11. Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs 2007;67(6):887-901.
12. Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006 Jun;61(6):737-42.
13. Virchow JC, Mehta A, Ljungblad L, Mitfessel H. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients. The Journal of Asthma 2010 Nov;47(9):986-93.
14. Baig S, Khan RA, Khan K, Rizvi N. Effectiveness and quality of life with montelukast in asthma – a double-blind randomized control trial. Pakistan Journal of Medical Sciences 2019;35(3):731-6.
15. Ikram A, Kumar V, Taimur M, Khan MA, Fareed S, Barry HD. Role of montelukast in improving quality of life in patients with persistent asthma. Cureus 2019 Jun;11(6):e5046.
16. Zuberi FF, Haroon MA, Haseeb A, Khuhawar SM. Role of montelukast in asthma and allergic rhinitis patients. Pakistan Journal of Medical Sciences 2020 Nov-Dec;36(7):1517-22.
17. Hon KLE, Leung TF, Leung AKC. Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Drug Design, Development and Therapy 2014 Jun;8:839-50.
18. Trink HKT, Lee SH, Cao TBT, Park HS. Asthma pharmacotherapy: an update on leukotriene treatments. Expert Review of Respiratory Medicine 2019 Dec;13(12):1169-78.
19. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA; Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003 Mar;58(3):211-6.
20. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf Accessed 2021 Mar 17.
21. Ministry of Health of the Russian Federation; Russian Respiratory Society. Federal clinical guidelines for diagnosis and treatment of bronchial asthma. 2019 revised. Available from: http://spulmo.ru/obshchestvo/news/news-812 Accessed 2021 Mar 17.
22. Broźek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich A, Brignardello-Petersen RB, Canonica GW, Casale T, Chavannes NH, Correia de Sousa JC, Cruz AA, Cuello-Garcia CA, Demoly P, Dykewicz M, Etxeandia-Ikobaltzeta I, Florez ID, Fokkens W, Fonseca J, Hellings PW, Klimek L, Kowalski S, Kuna P, Laisaar KT, Larenas-Linnemann DE, Carlsen KCL, Manning PJ, Meltzer E, Mullol J, Muraro A, O’Hehir R, Ohta K, Panzner P, Papadopoulos N, Park HS, Passalacqua G, Pawankar R, Price D, Riva JJ, Roldán Y, Ryan D, Sadeghirad B, Samolinski B, Schmid-Grendelmeier P, Sheikh A, Togias A, Valero A, Valiulis A, Valovirta E, Ventresca M, Wallace D, Waserman S, Wickman M, Wiercioch W, Yepes-Nuñez JJ, Zhang L, Zhang Y, Zidarn M, Zuberbier T, Schünemann HJ. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. The Journal of Allergy and Clinical Immunology 2017 Oct;140(4):950-8.
23. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, Klimekj L, Pfaar O, Wallace D, Ansotegui I, Agache I, Bedbrook A, Bergmannj KC, Bewick M, Bonniaud P, Bosnic-Anticevich S, Bossé I, Bouchard J, Boulet LP, Brozek J, Brusselle G, Calderon MA, Canonica WG, Caraballo L, Cardona V, Casale T, Cecchi L, Chu DK, Costa EM, Cruz AA, Czarlewski W, D’Amato G, Devillier P, Dykewicz M, Ebisawa M, Fauquert JL, Fokkens WJ, Fonseca JA, Fontaine JF, Gemicioglu B, van Wijk RG, Haahtela T, Halken S, Ierodiakonou D, Iinuma T, Ivancevich JC, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Tebbe JK, Kowalski ML, Kuna P, Kvedariene V, La Grutta S, Larenas-Linnemann D, Lau S, Laune D, Le L, Lieberman P, Carlsen KCL, Lourenço O, Marien G, Carreiro-Martins P, Melén E, Menditto E, Neffen H, Mercier G, Mosgues R, Mullol J, Muraro A, Namazova L, Novellino E, O’Hehir R, Okamoto Y, Ohta K, Park HS, Panzner P, Passalacqua G, Pham-Thi N, Price D, Roberts G, Roche N, Rolland C, Rosario N, Ryan D, Samolinski B, Sanchez-Borges M, Scadding GK, Shamji MH, Sheikh A, Bom AM, Toppila-Salmi S, Tsiligianni I, Valentin-Rostan M, Valiulis A, Valovirta E, Ventura MT, Walker S, Waserman S, Yorgancioglu A, Zuberbier T; Allergic Rhinitis and Its Impact on Asthma Working Group. Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. The Journal of Allergy and Clinical Immunology 2020 Jan;145(1):70-80.e3.
24. U.S. Food and Drug Administration. Singulair. Prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020829s073,020830s075,021409s051lbl.pdf Accessed 2020 Mar 17.
25. Ilina NI, Kurbacheva OM, Nenasheva NM, Astafyeva NG, Beltyukov EK, Demko IV, Zhestkov AV, Osipova GL. Safety and efficacy of antileukotriene drugs: relevant data. RAACI experts conclusion. Russian Allergological Journal 2020;17(3):121-9 (In Russian).
26. Brodskaya ON, Makarova MA, Belevskiy AS. Montelukast: concerns need proof. Practical Pulmonology 2020;1:107-16 (In Russian).

  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]